Effectiveness and safety of dupilumab in children with moderate-to-severe asthma in China: A retrospective real-world study.
10.1097/CM9.0000000000003508
- Author:
Lihong SUN
1
;
Yingtong YE
2
;
Shunkai HUANG
1
;
Xu QIN
1
;
Lijun ZENG
1
;
Yilin GUO
1
;
Lanying CHENG
1
;
Nanshan ZHONG
3
Author Information
1. Department of Pediatric Pulmonology, the First Affiliated Hospital of Guangzhou Medical University, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, Guangdong 510000, China.
2. State Key Laboratory of Respiratory Disease, Guangzhou Medical University, Guangzhou, Guangdong 510000, China.
3. Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Guangzhou Medical University, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou, Guangdong 510000, China.
- Publication Type:Journal Article
- From:
Chinese Medical Journal
2025;138(8):1003-1005
- CountryChina
- Language:English
